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A B S T R A C T 
Background: β-lactamase is an enzyme that plays a role in the occurrence of antibiotic 
resistance against Methicillin-resistant Staphylococcus aureus (MRSA) bacteria. Viscosin is a 
lipopeptide biosurfactant produced by the Pseudomonas group bacteria. A study states that 
Viscosin has strong antibacterial properties.  
Aim: This study aims to determine the interactions that occur with Viscosin and β-lactamase 
enzymes.  
Methods: Researchers used the in-silico method to determine the molecular interactions that 
occurred computationally. The protein used was β-lactamase protein obtained from the 
Protein Data Bank and Viscosin ligand obtained from the PubChem web server, and we used 
native ligands as control. Pharma expert web server and Pyrx, Pymol, and Discovery Studio 
software were used in this research.  
Results: The results showed that Viscosin has high activity as an antibiotic and is predicted to 
be a membrane integrity antagonist. The binding affinity interaction that occurs between 
Viscosin-β-lactamase is -7.3 kcal/mol. The affinity is lower than the control.  
Conclusion: Viscosin was predicted to have strong antibacterial properties, but the binding 
interaction was lower than the control. However, exploration of Viscosin compounds and 
further study to determine the antibacterial effect of Viscosin against MRSA and other bacteria 
is needed to against antibiotic resistance. 
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I N T R O D U C T I O N
Methicillin-resistant Staphylococcus 
aureus (MRSA) is a pathogenic strain of 
Staphylococcus aureus bacteria, highly 
infectious and resistant to the antibiotic 
methicillin. The resistance mechanism is 
mediated by various virulence factors, one of 
which is the β-lactamase enzyme, which has a 
low affinity for β-lactam antibiotics.(1) Besides, 
MRSA is also a significant cause of hospital 
acquired infections. MRSA can cause skin 
infections, surgical site infections, systemic 
infections.(2) These infections extend from 
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superficial skin infections to more severe 
diseases such as bronchopneumonia.(3) 
Viscosin is a lipopeptide biosurfactant 
produced by the Pseudomonas bacteria group. 
A study states that this lipopeptide has 
antibacterial, antifungal properties against the 
fungus Aspergillus fumigatus. This lipopeptide 
is also produced by the bacteria Pseudomonas 
fluorescens.(4–7) In previous studies, 
Pseudomonas fluorescens membrane extracts' 
ability to have an antibacterial activity that can 
destroy the integrity of tuberculosis cell 
membranes.(5,8) 
Drug design studies take a longer time, 
but screening to determine the potential of a 
compound as a drug candidate at this time can 
be done with the in-silico approach. In addition, 
simulation of drug design interactions using 
silicone can predict an interaction mechanism 
between the ligand and target protein and the 
bond energy.(9 This study will predict the 
molecular interaction mechanism between 
Viscosin as an antibiotic candidate against 
MRSA using in-silico approach. 
M E T H O D S 
Study Design 
 This study used in silico method using 
the β-lactamase enzyme class C protein 
sequence obtained from the Protein Data Bank. 
Β-lactamase enzyme structure had obtained 
with the code: 4OOY. The ligand used was the 
Viscosin compound obtained from Pubchem 
with the CID Pubchem compound code: 
1341283019. 
Protein and Ligan Preparation 
 Protein stabilization was carried out to 
adjust to the body's physiology using PyMOL by 
removing water atoms and adding hydrogen 
atoms. This software Viscosin protein is 
obtained from the PubChem database (CID 
6711494) and then optimized using PyRx. The 
control ligands used was native β-lactamase 
enzyme protein ligands, namely (2s, 5r) -1-
Formyl-5 - [(Sulfooxy) amino] piperidine-2-
Carboxamide, which had downloaded in the 
form of .sdf.(10,11) 
Prediction Analysis of Viscosin Compounds 
Activity 
Molecular docking using a personal 
computer with Windows 10 specifications, 
16GB RAM, SSD 210, Rayzen 5 2400U processor. 
Prediction of Viscosin compounds has been 
carried out using computational studies by 
tracing the activity relationship (SAR) structure 
on the webserver 
(http://www.pharmaexpert.ru/passonline/pre
dict.php). The probability value of active (Pa) of 
Viscosin compounds was predicted by 
including the SMILES of Viscosin, downloaded 
via PubChem.(12) 
Visualization of Ligand and Protein 
Interactions 
Molecular docking of viscosin to β-
lactamase protein has been performed using 
PyMOL, PyRx, and Discovery Studio software. 
The docking process obtains the bond strength 
between the Viscosin compound and the β-
lactamase enzyme protein by predicting the 
results of binding affinity and knowing the 
specification of bond interactions.(10,11) 
R E S U L T S& DISCUSSION 
Prediction of Potential Benefits of Viscosin 
Compounds 
A pharmaexpert is a web server that 
provides a database to predict a compound's 
property or effect by entering the SMILE 
sequence. The data obtained will have an active 
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probability (Pa) and an inactive probability 
(Pi).(13) 
Table 1. Viscosin Activity Prediction 
Pa Pi Activity 
0.859 0.002 Antibiotic Glycopeptide-Like 
0.809 0.005 Antifungal 
0.753 0.010 Membrane Integrity Antagonist 
Active probability can be data that 
looks at the possibility of a compound having 
this property. Meanwhile, Pi is the possibility 
that a compound does not have these 
properties in experimental. The compound has 
strong properties if Pa>0.7 and has low possible 
experimental if Pa<0.512.(13)The screening of 
Viscosin compounds' properties showed that 
Viscosin has activity as a Glycopeptide-Like 
antibiotic with Pa 0.859 and Pi 0.002 and as 
Membrane Integrity Antagonist with Pa 0.753 
and Pi  0.010. From these results, we know that 
it is likely that Viscosin has these properties. 
Glycopeptide antibiotics have become 
a leading natural product derived antibiotics 
that possess a mechanism of action in bacterial 
cell wall assembly inhibition. The inhibition 
occurred by interferes with peptidoglycan 
synthesis.(14) The glycopeptide antibiotics such 
as Vancomycin and Teicoplanin have broad-
spectrum antibacterial activity and are used as 
a drug of choice for MRSA infection.(15,16) 
Glycopeptide antibiotics appointed as 
restricted used antibacterial to be the critical 
solution against drug-resistant bacteria. The 
recently approved Glycopeptides antibiotics, 
including second-generation semisynthetic 
lipoglycopeptide (Telavancin and Oritavancin) 
and second-generation teicoplanin-type 
glycopeptide (Dalbavancin), arise with some 
modification and better ADME properties than 
previous glycopeptide class. Those inventions 
become examples of subsequent antibacterial 
development.(16) The findings of Viscosin as 
Glycopeptide-like antibacterial in this study 
indicates the potential vision of novel 
glycopeptide antibiotics against MRSA and 
other bacteria. 
Membrane integrity antagonist role in 
the antibacterial mechanism of action shows 
the chemical ability to reduce cell viability. 
Previous Glycopeptide antibiotic, such as 
Telavancin has a similar ability to disrupt 
membrane integrity.(17) Consistent with earlier 
findings of cell wall inhibition synthesis as 
Glycopeptide-like antibiotics, the activity of 
membrane integrity antagonist of Viscosin 
reveal the ability against Gram-positive 
bacteria, specifically MRSA. In addition, 
membrane integrity inhibition is already known 
as the pathway inhibited by lipopeptide class 
antibacterial.(18)It was consistent with the 
properties of Viscosin, which is known that 
Viscosin is a lipopeptide biosurfactant 
produced by the Pseudomonas bacteria group 
and from previous studies, the biological 
activity of the compound was antibacterial.(4–7)
Binding Affinity and Interaction of Viscosin with β-lactamase 
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 PyRx 9.5 software was used to assess 
the strength of the interaction between ligands 
and target proteins. The prediction of bond 
strength was done with grid box center X: -
6.253, Y: -3,172 and Z: 17,778, dimension X: 
64,991, Y: 61,759 Z: 64,760. The interaction bond 
between Viscosin and β-lactamase has a bond 
energy of -7.3 kcal/mol. When compared with 
the control ligand interaction, the affinity of (2s, 
5r) -1-Formyl-5 - [(Sulfooxy) amino], piperidine-
2-Carboxamideis stronger than Viscosin 
because it has a more negative energy 
binding.(11) 





Ligand Interaction with the protein target 
The 
bond 
4OOY β-Lactamase Viscosin Hydrogen bond:  
Asp149, Asn347, Asn373, Arg376, Ser345 
5 




Hydrogen bond: Arg376,Ser345, Lys342, 
Asn314, Thr343, Glu299, Arg175 
7 
Hydrophobic interaction: Tyr177,Ala319 2 











Figure 1. Visualization Interaction between Viscosin – Protein β-Lactamase (upper) and (2s,5r)-1-Formyl-5-
[(Sulfooxy)amino]piperidine-2-Carboxamide (Control)-β-lactamase (Lower) 
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The visualization of the bond 
interaction between Viscosin and the β-
Lactamase enzyme protein shown in Figure 1, 
were compared with the control ligand and β-
lactamase, which has the same residual amino 
acid. Viscosin has five hydrogen bonds, namely 
the residual amino acids Asp149, Asn347, 
Asn373, Arg376, Ser345, and has three 
hydrophobic bonds to the amino acids Tyr177, 
Ala319, Val239. Hydrogen interactions Arg376, 
Ser345, and hydrophobic interactions Tyr177, 
Ala319 have similarities with control ligand-β-
lactamase. The similarity of the residual amino 
acid bonds indicates the similarity of the 
properties with the control so that Viscosin can 
inhibit the β-lactamase enzyme's action.(20) 
β-lactamase is an enzyme that is 
responsible for any failures of β-lactam 
antibiotic therapy. β-lactamase's crystalline 
structure in Gram-positive Staphylococcus 
aureus has been found with a resolution of 2.5 
angstroms.(19–21)However, this study result is the 
prediction potential of viscosin and β-
lactamase interaction by molecular docking 
analysis. Therefore, further study is needed to 
reveal the antibacterial mechanism for MRSA 
and other bacteria by viscosin. Regarding the 
emergence of antibacterial resistance 
worldwide, the challenges of discovering and 
developing novel antibacterial are exploring 
multiple aspects of bacteria and revealing other 
potential mechanisms in future antibacterial 
research. 
C O N C L U S I O N 
Viscosin has properties as Antibiotic 
Cyclopeptides-Like and antagonist integrity 
membranes. In addition, Viscosin can bind β-
lactamase by Hydrogen and hydrophobic 
interactions. However, the strength of the bond 
interaction between Viscosin and β-lactamase 
is strong but still lower than control. Therefore, 
further tests are needed to assess the effect of 
Viscosin on MRSA and other bacteria by in vivo 
and in vitro tests. 
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